Calumet Stock: Fits Strongly Within The ‘Moderate Danger, High Reward’ Portfolio Pail

Science technology concept. Research and Development. Drug discovery.


The following section was excerpted from this fund letter.

Calumet Specialized Products Partners ( NASDAQ: CLMT)

We just recently started a financial investment in Calumet in the event-driven portfolio. Calumet fits strongly within the “moderate threat, high benefit” container of our portfolio for factors that will be

Like this post? Please share to your friends:
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: